Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Curt Oltmans Net Worth & Insider Trades

Curt Oltmans - Chief Legal Officer, Fulcrum Therapeutics, Inc

As of April 28, 2023

What is Curt Oltmans's Net Worth?

The current estimated net worth of Fulcrum Therapeutics, Inc's Chief Legal Officer, Curt Oltmans, is estimated to be about $1.72M . Curt Oltmans owns about 1,088 units of Fulcrum Therapeutics, Inc common stock. In the last 3 years at Fulcrum Therapeutics, Inc, Curt Oltmans has sold an estimated value of $0 worth.

What is Curt Oltmans's Past Insider Trading?

Curt Oltmans's largest purchase order was 1,088 units , worth over $9.8K on June 29, 2021. In total, Curt Oltmans has made about 6 transactions over 3 years of their time at Fulcrum Therapeutics, Inc. Curt Oltmans usually trades in December, August, February, April, January and June, with the busiest year in 2023 and 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Curt Oltmans

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Curt Oltmans's' Mailing Address?

  • Mailing address is C/o Array Biopharma Inc. 3200 Walnut St. Boulder CO 80301 CO

What are Fulcrum Therapeutics, Inc's Past Insider Trades?

Fulcrum Therapeutics, Inc's most recent insider trade came on May 11, 2023 by Greg Tourangeau who sold 210 units worth $695.1 . In the last 4 years, insiders at Fulcrum Therapeutics, Inc have sold an estimated value of $7.48M and bought an estimated value of $52.6M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Robert J Gould, Interim President & CEO,  Diego Cadavid, SVP Clinical Development,  and Owen B Wallace, Chief Scientific Officer .

Fulcrum Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...